Status:

COMPLETED

Long Term Effects of Treating Submassive Pulmonary Embolism With Ultra-sound Accelerated Thrombolysis

Lead Sponsor:

Corewell Health West

Collaborating Sponsors:

EKOS Corporation

Conditions:

Submassive Pulmonary Embolism

Eligibility:

All Genders

18-80 years

Brief Summary

Patients with Submassive Pulmonary Embolism treated with ultra-sound therapy will have an improved right ventricular function 72 hours post treatment.

Eligibility Criteria

Inclusion

  • Patients with acute (\< or = 14 days)symptomatic pulmonary embolism by CT Angiogram of the thorax with embolus involving at least one main or lower lobe pulmonary artery and RV:LV ratio \> 0.9

Exclusion

  • age \> 80
  • Recent thrombolytic therapy (with in 4 days)
  • Active bleeding or know bleeding diathesis
  • Known coagulopathy (including treatment with vitamin K antagonists) INR \> 3 and/or PTT \> 50
  • Thrombocytopenia (PLT cound \< 100,000)
  • History of any intracranial or intraspinal surgery, trauma or bleed
  • Intracranial neoplasms, AVM, or aneurysm
  • Recent (\< 1 month) GI bleed
  • Recent (\< 3 months) internal eye surgery or hemorrhagic retinopathy
  • Recent (\< 7 days) major surgery, trauma, or obstetrical delivery
  • Renal insufficiency with eGFR \< 45 ml/min
  • Known allergy, hypersensitivity, or thrombocytopenia from heparin or tPA
  • Hemodynamic instability defined as need for cardiopulmonay resuscitation, Systolic BP \> 90 mm Hg for \> 15 min or need for pressor agents to maintain BP \> 90.
  • Severe Hypertension (sustained systolic \> 180 mm Hg or diastolic \> 90 mm Hg.
  • Pregnant patients
  • known right to left shunt
  • Large (\>10 mm)intracardiac thrombus
  • Use of thrombolytics or glycoprotein IIb/IIIa antangonists within 3 days of inclusion.
  • Life expectancy \< 30 days

Key Trial Info

Start Date :

May 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 1 2019

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT01899339

Start Date

May 1 2013

End Date

February 1 2019

Last Update

July 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Spectrum Health Hospitals

Grand Rapids, Michigan, United States, 49503